| Product Code: ETC6900795 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The oral antiviral import market in Cyprus has seen steady growth with top exporters like Greece, Germany, Netherlands, Switzerland, and Vietnam dominating the scene in 2024. The market concentration, as indicated by the HHI, remained at a moderate level, suggesting a healthy level of competition. The impressive compound annual growth rate (CAGR) of 10.34% from 2020 to 2024 and a notable growth rate of 13.05% in 2023-24 further underscore the increasing demand for oral antivirals in Cyprus. This data indicates a promising outlook for the market in the coming years.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Cyprus Oral Antiviral Market Overview |
3.1 Cyprus Country Macro Economic Indicators |
3.2 Cyprus Oral Antiviral Market Revenues & Volume, 2021 & 2031F |
3.3 Cyprus Oral Antiviral Market - Industry Life Cycle |
3.4 Cyprus Oral Antiviral Market - Porter's Five Forces |
3.5 Cyprus Oral Antiviral Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 Cyprus Oral Antiviral Market Revenues & Volume Share, By Drug class, 2021 & 2031F |
3.7 Cyprus Oral Antiviral Market Revenues & Volume Share, By Distribution channel, 2021 & 2031F |
4 Cyprus Oral Antiviral Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Cyprus Oral Antiviral Market Trends |
6 Cyprus Oral Antiviral Market, By Types |
6.1 Cyprus Oral Antiviral Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 Cyprus Oral Antiviral Market Revenues & Volume, By Indication, 2021- 2031F |
6.1.3 Cyprus Oral Antiviral Market Revenues & Volume, By Hepatitis, 2021- 2031F |
6.1.4 Cyprus Oral Antiviral Market Revenues & Volume, By Human Immunodeficiency Virus (HIV), 2021- 2031F |
6.1.5 Cyprus Oral Antiviral Market Revenues & Volume, By Influenza, 2021- 2031F |
6.1.6 Cyprus Oral Antiviral Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Cyprus Oral Antiviral Market, By Drug class |
6.2.1 Overview and Analysis |
6.2.2 Cyprus Oral Antiviral Market Revenues & Volume, By Protease inhibitors, 2021- 2031F |
6.2.3 Cyprus Oral Antiviral Market Revenues & Volume, By Reverse transcriptase inhibitors, 2021- 2031F |
6.2.4 Cyprus Oral Antiviral Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Cyprus Oral Antiviral Market, By Distribution channel |
6.3.1 Overview and Analysis |
6.3.2 Cyprus Oral Antiviral Market Revenues & Volume, By Hospital pharmacies, 2021- 2031F |
6.3.3 Cyprus Oral Antiviral Market Revenues & Volume, By Drug store and retail pharmacies, 2021- 2031F |
6.3.4 Cyprus Oral Antiviral Market Revenues & Volume, By Online providers, 2021- 2031F |
7 Cyprus Oral Antiviral Market Import-Export Trade Statistics |
7.1 Cyprus Oral Antiviral Market Export to Major Countries |
7.2 Cyprus Oral Antiviral Market Imports from Major Countries |
8 Cyprus Oral Antiviral Market Key Performance Indicators |
9 Cyprus Oral Antiviral Market - Opportunity Assessment |
9.1 Cyprus Oral Antiviral Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 Cyprus Oral Antiviral Market Opportunity Assessment, By Drug class, 2021 & 2031F |
9.3 Cyprus Oral Antiviral Market Opportunity Assessment, By Distribution channel, 2021 & 2031F |
10 Cyprus Oral Antiviral Market - Competitive Landscape |
10.1 Cyprus Oral Antiviral Market Revenue Share, By Companies, 2024 |
10.2 Cyprus Oral Antiviral Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |